Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 18:02:28 06/11/2026 HKT			5-day change	1st Jan Change
2,524.85 ^INR	+0.97%		+1.66%	+2.18%

11-04	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI
08-03	GSK India first-quarter profit rises on steady vaccine demand	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	427,725	-	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	10.57%	-	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	427,725	427,725	427,725
Change	-	-18.99%	58.51%	48.08%	-20.64%	10.57%	0%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	37x	32.1x	30.6x
PBR	10.6x	12.9x	18.5x	25x	17.1x	16.3x	12.7x	-
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.2x	2.1x	6.17x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10x	9.04x	8.62x
EV / Revenue	0x	0x	0x	0x	0x	10x	9.04x	8.62x
EV / EBITDA	0x	0x	0x	0x	0x	29x	25.2x	24.2x
EV / EBIT	0x	0x	0x	0x	0x	26.6x	25x	-
EV / FCF	0x	0x	0x	0x	0x	35.6x	32.5x	30.5x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.81%	3.08%	3.28%
Dividend per Share ²	30	32	32	42	57	29.5	29.5	-
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.17%	1.17%	-
EPS ²	100	36.05	34.83	54.76	61.15	68.23	78.6	82.5
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.2%	37.5%	-
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,680	47,337	49,621
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,764	16,962	17,694
EBIT ¹	7,592	7,385	8,390	11,106	12,428	16,096	17,107	-
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,561	13,320	13,979
Net Debt	-25,363	-16,656	-	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,524.85	2,524.85	2,524.85
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-	-
Announcement Date	16/5/22	17/5/23	17/5/24	13/5/25	13/5/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	37x	-	-	1.17%	4.55B
ELI LILLY AND COMPANY	39.62x	13.42x	28.51x	0.5%	1,206B
JOHNSON & JOHNSON	40.43x	6.79x	19.09x	1.93%	665B
ABBVIE INC.	37.45x	8.51x	17.57x	2.38%	515B
ROCHE HOLDING AG	20.98x	5.12x	12.74x	2.57%	381B
MERCK & CO., INC.	97.18x	5.95x	25.33x	2.32%	362B
NOVARTIS AG	23.18x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.46x	4.89x	13.77x	1.79%	289B
AMGEN INC.	23.66x	7.32x	13.53x	2.19%	249B
GILEAD SCIENCES, INC.	-39.95x	7.29x	45.82x	1.98%	207B
Average	30.40x	7.25x	21.19x	1.95%	418.43B
Weighted average by Cap.	35.62x	8.55x	21.86x	1.73%